子宫操作设备市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

2024 年全球子宫操纵设备市场估值达 3.67 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 5.2%。这一增长是由子宫内膜异位症和子宫肌瘤等妇科疾病的发生率不断上升所推动的，这推动了对子宫切除术和肌瘤切除术等外科手术的需求。此外，辅助生殖技术的进步、微创手术技术的日益采用以及向门诊护理环境的转变在扩大市场方面发挥着至关重要的作用。这些因素，加上人们对女性健康的认识不断提高以及创新医疗设备的普及，促使子宫操纵装置在全球范围内广泛应用。由于高度重视改善患者的治疗效果和手术效率，医疗保健提供者越来越多地转向使用先进的工具来提高妇科手术的精确度。

根据设备类型，市场分为一次性子宫操纵设备及可重复使用子宫操纵设备，其中一次性设备占据主导地位。一次性设备因其便利性和能够满足严格的无菌标准而受到青睐，2024 年的价值为 2.282 亿美元。这些一次性设备无需进行消毒过程，为医疗机构节省了时间和资源，特别是在高容量手术环境中。随着强调感染控制和手术安全的法规日益增多，一次性子宫操作器的采用也得到了进一步的推动。随着医院和门诊护理中心优先考虑效率和合规性，一次性设备的需求持续增长。

根据最终用户，子宫操纵设备市场包括医院、妇科诊所和门诊手术中心。医院仍然是妇科手术的主要场所，例如肌瘤切除术、子宫切除术、生育手术和子宫内膜异位症治疗，2024 年医院支出为 1.981 亿美元。人们对微创手术（包括全腹腔镜子宫切除术 (TLH)）的偏好日益增加，推动了对支持精准度和缩短恢復时间的子宫操作设备的需求。随着患者偏好转向微创治疗，医院越来越多地配备先进的工具来提高手术效果。

美国子宫操纵设备市场价值在 2024 年达到 1.154 亿美元，预计到 2034 年将以 4.4% 的复合年增长率增长。子宫肌瘤和子宫内膜异位症等妇科疾病的发生率不断增加，推动了对手术解决方案的需求。美国市场的特点是早期采用创新医疗技术，对优先考虑安全性、准确性和易用性的产品的需求很高。一次性子宫操作器因其在降低手术期间感染风险方面的作用而越来越受欢迎，使其成为全国各地医院和门诊手术中心的首选。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 妇科疾病发生率不断上升
    • 认知度和诊断率不断提高
    • 产品技术的进步以及外科手术的增多
  • 产业陷阱与挑战
    • 手续费用高且监管严格
• 成长潜力分析
• 监管格局
• 技术格局
• 报销场景
• 差距分析
• 波特的分析
• PESTEL 分析
• 未来市场趋势

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按类型，2021 — 2034 年

• 主要趋势
• 一次性的
• 可重复使用的

第六章：市场估计与预测：按应用，2021 — 2034 年

• 主要趋势
• 全腹腔镜子宫切除术 (TLH)
• 腹腔镜子宫切除术 (LSH)
• 腹腔镜辅助阴道子宫切除术 (LAVH)
• 其他应用

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 妇科诊所
• 门诊手术中心

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• B. Braun
• Bissinger
• Conkin surgical instruments
• Conmed
• Coopersurgical
• Karl storz
• Laborie
• Lsi solutions
• Purple surgical
• Richard wolf
• Utah medical products

The Global Uterine Manipulation Devices Market reached a valuation of USD 367 million in 2024 and is projected to expand at a CAGR of 5.2% between 2025 and 2034. This growth is fueled by the increasing prevalence of gynecological conditions such as endometriosis and uterine fibroids, which are driving the demand for surgical interventions like hysterectomies and myomectomies. Additionally, advancements in assisted reproductive technologies, the rising adoption of minimally invasive surgical techniques, and the shift toward outpatient care settings are playing a crucial role in expanding the market. These factors, combined with growing awareness of women's health and the availability of innovative medical devices, are contributing to the widespread adoption of uterine manipulation devices globally. With a strong focus on improving patient outcomes and procedural efficiency, healthcare providers are increasingly turning to advanced tools that enhance precision during gynecological surgeries.

The market is segmented by device type into disposable and reusable uterine manipulation devices, with disposable devices maintaining a dominant share. Valued at USD 228.2 million in 2024, disposable devices are favored for their convenience and ability to meet stringent sterility standards. These single-use devices eliminate the need for sterilization processes, saving time and resources for healthcare facilities, particularly in high-volume surgical environments. The adoption of disposable uterine manipulators is further bolstered by increasing regulations emphasizing infection control and surgical safety. As hospitals and outpatient care centers prioritize efficiency and compliance, the demand for disposable devices continues to grow.

By end-user, the uterine manipulation devices market encompasses hospitals, gynecology clinics, and ambulatory surgery centers. Hospitals, which accounted for USD 198.1 million in 2024, remain the primary venues for gynecological surgeries such as myomectomies, hysterectomies, fertility procedures, and treatments for endometriosis. The rising preference for minimally invasive surgeries, including total laparoscopic hysterectomy (TLH), is driving the demand for uterine manipulation devices that support precision and reduced recovery times. As patient preferences shift toward minimally invasive options, hospitals are increasingly equipping themselves with advanced tools to enhance surgical outcomes.

The U.S. uterine manipulation devices market, valued at USD 115.4 million in 2024, is expected to grow at a CAGR of 4.4% through 2034. The increasing incidence of gynecological diseases such as uterine fibroids and endometriosis is fueling the demand for surgical solutions. The U.S. market is characterized by the early adoption of innovative medical technologies, creating high demand for products that prioritize safety, accuracy, and ease of use. Disposable uterine manipulators, in particular, are gaining popularity for their role in minimizing infection risks during surgeries, making them a preferred choice in hospitals and ambulatory surgery centers across the country.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of gynecological disorders
    • 3.2.1.2 Growing awareness and diagnosis rates
    • 3.2.1.3 Technological advancements in products coupled with rise in surgical procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of procedures and stringent regulations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 — 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Disposable
• 5.3 Reusable

Chapter 6 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Total Laparoscopy Hysterectomy (TLH)
• 6.3 Laparoscopic Supracervical Hysterectomy (LSH)
• 6.4 Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Gynecology clinics
• 7.4 Ambulatory surgery centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. Braun
• 9.2 Bissinger
• 9.3 Conkin surgical instruments
• 9.4 Conmed
• 9.5 Coopersurgical
• 9.6 Karl storz
• 9.7 Laborie
• 9.8 Lsi solutions
• 9.9 Purple surgical
• 9.10 Richard wolf
• 9.11 Utah medical products